Until Labs raised $58M in Series A funding pioneer reversible cryopreservation, starting with organs for transplants and roadmapping toward medical hibernation. The approach combines cryoprotectants, perfusion protocols, and custom cooling hardware to avoid ice damage in tissues, extending viability beyond traditional cold-chain methods and enabling better logistics for donor matching. The round was led by Founders Fund.
- Company
- Until Labs untillabs.com
- Round
- Series A
- Amount
- $58M
- Source
- untillabs.com
- In the newsletter
- No. 206, Boston Dynamics’ Forbidden Teardown